Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 28, 2025
BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer
GlobeNewswire
·
May 28, 2025
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the “combined company”), which today acquired Streamex Exchange Corporation (“Streamex”) as its wholly owned subsidiary, announced the …
Lavior Pharma Wins Award for Transforming Wound Care Through Bio-Engineered Botanicals
EIN Presswire
·
May 28, 2025
Honored for leading the way in clinically proven, bio-engineered botanical solutions that are changing lives worldwide. MIAMI, FL, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Lavior Pharma is proud to announce it has been honored with the Small …
Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq
GlobeNewswire
·
May 28, 2025
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced successful completion …
Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032 | DelveInsight
GlobeNewswire
·
May 28, 2025
New York, USA, May 28, 2025 (GLOBE NEWSWIRE) -- Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032 | DelveInsight The AI in precision medicine market is experiencing significant growth, …
Veyond Metaverse Secures Strategic Funding to Accelerate Commercial Launch of SkyDoc and MaritimeDoc
GlobeNewswire
·
May 28, 2025
SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- Veyond Metaverse, a pioneer in 5D XR real-time immersive communication technology, announced today that it has closed a strategic financing round from a private investor. The new capital will accelerate the …
NFL Standouts Bring the Conversation on Psychedelic Healing to Psychedelic Science 2025
GlobeNewswire
·
May 28, 2025
Jordan Poyer, Jon Feliciano, and Robert Gallery join Aubrey Marcus to share candid stories of healing, brotherhood, and the work they are doing now. Attendees will explore the emotional and neurological impact of elite competition—and discover how …
Benevis Celebrates Decade-Long Impact of Delivering Free Dental Care to Over 3,800 Uninsured Children and Adults During Sharing Smiles Day
GlobeNewswire
·
May 28, 2025
Atlanta, GA, May 28, 2025 (GLOBE NEWSWIRE) -- Benevis is proud to share that over the course of the last 10 years, company volunteers have positively impacted the oral health of more than 3,800 uninsured and underinsured patients during Sharing Smiles Day. …
Calgary refugees have their healthcare services saved temporarily thanks to Calgary Health Foundation donors
GlobeNewswire
·
May 28, 2025
Calgary, Alberta, Canada, May 28, 2025 (GLOBE NEWSWIRE) -- Calgary Health Foundation is proud to announce a commitment to the Calgary Refugee Health Clinic, one that will secure its operations for the next two years. The $550K promise, made possible thanks …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
GlobeNewswire
·
May 28, 2025
HOUSTON, TX, May 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on June 3, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin’s game- …
Local Neurosurgeon Jeremy Denning Raises Awareness for National Scoliosis Month
GlobeNewswire
·
May 28, 2025
PLANO, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- June is National Scoliosis Awareness Month – an ideal time to explore causes and treatment methods for scoliosis, which affects approximately 7 million people in the United States, as reported by the National …
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- As the burden of food allergies continues to increase each year, the need for safe, effective, and convenient treatments has never been greater. Over 33 million Americans suffer from food allergies, including …
AI GPO Launches as Nation’s First AI-Focused Group Purchasing Organization, Democratizing Advanced AI Technology and Essential Business Savings
GlobeNewswire
·
May 28, 2025
ROCHESTER, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- AI GPO, the world’s first Group Purchasing Organization (GPO) singularly focused on Artificial Intelligence, today announced its national launch. The company is set to democratize access to the latest AI …
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
GlobeNewswire
·
May 28, 2025
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
GlobeNewswire
·
May 28, 2025
LAS VEGAS, May 28, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), through its pets division PawPa™, a leader in premium pet wellness, proudly announces the remarkable stem cell benefits of its flagship product, Regen Dog Chews, …
Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando
GlobeNewswire
·
May 28, 2025
ORLANDO, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a leading innovator in the pharmaceutical industry, is proud to announce it has secured $637,500 in workforce training funds to support the continued expansion of its sister brand, …
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
GlobeNewswire
·
May 28, 2025
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and Trademark Office (USPTO) for a new …
Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System
GlobeNewswire
·
May 28, 2025
Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has received FDA 510(k) clearance for the use of its DEXTER …
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
GlobeNewswire
·
May 28, 2025
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled "Lamin B Receptor (LBR) as an Immunotherapeutic …
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic …
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …